
ALXO
Healthcare · Biotechnology · $143.8M market cap
$1.04-0.04 (-3.7%)Nov 13, 4:21 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · +11.6% over 90 days · 30-day revisions 4 up, 1 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 13, 2026 | Time not confirmed | -0.14 | — | — |
| Aug 6, 2026 | Before the open | -0.15 | -0.13 | +13.3% |
| May 8, 2026 | Before the open | -0.15 | -0.17 | -13.3% |
| Mar 5, 2026 | Time not confirmed | -0.35 | -0.37 | -4.9% |
| Nov 7, 2025 | Before the open | -0.37 | -0.41 | -10.8% |
| Aug 12, 2025 | After the close | -0.31 | -0.44 | -41.9% |
| May 7, 2025 | Before the open | -0.31 | -0.48 | -54.5% |
| Mar 6, 2025 | After the close | -0.39 | -0.44 | -12.8% |
| Nov 7, 2024 | After the close | -0.66 | -0.58 | +12.1% |
| Aug 8, 2024 | After the close | -0.70 | -0.62 | +11.4% |
| May 9, 2024 | After the close | -0.71 | -0.71 | 0.0% |
| Mar 7, 2024 | After the close | -0.84 | -0.93 | -10.7% |
| Nov 13, 2023 | After the close | -0.89 | -1.24 |
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company's lead product candidate is Evorpacept, a CD47 blocking therapeutic biologic development as a combination therapy with other anti-cancer agents, including ASPEN-06, under phase 2 clinical study for treating Gastric/GEJ cancer. It has collaboration agreement for…
| -39.3% |
| Aug 10, 2023 | After the close | -0.86 | -0.83 | +3.5% |
| May 11, 2023 | After the close | -0.80 | -0.74 | +7.5% |
| Mar 9, 2023 | After the close | -0.89 | -0.75 | +15.7% |
| Nov 8, 2022 | After the close | -0.74 | -0.87 | -17.6% |
| Aug 8, 2022 | After the close | -0.61 | -0.81 | -32.8% |
| May 9, 2022 | After the close | -0.68 | -0.60 | +11.8% |
| Feb 28, 2022 | Before the open | -0.62 | -0.70 | -12.9% |
| Nov 11, 2021 | After the close | -0.49 | -0.61 | -24.5% |
| Aug 12, 2021 | After the close | -0.45 | -0.40 | +11.1% |
| May 17, 2021 | After the close | -0.34 | -0.35 | -2.9% |
| Mar 18, 2021 | After the close | -0.35 | -0.48 | -37.1% |
| Nov 12, 2020 | After the close | -0.34 | -0.33 | +2.9% |
| Aug 27, 2020 | After the close | -0.44 | -2.54 | -477.3% |
| Jun 3, 2020 | Time not confirmed | -0.25 | -0.25 | +0.6% |